INSIGHTS ON DRUG DEVELOPMENT
-
Multifactorial Disease Models: De-Risking Topical Formulation Development
Traditional drug models fail to predict performance in human skin. Advanced, multifactorial ex vivo disease models directly address inflammation and infection to de-risk formulation development.
-
How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions
With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence
-
A Study To Assess Organoid Size And Cell Count From 3D Image Analysis
Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.
-
Safety, Containment, And Analysis Of Highly Potent Compounds
Explore a comprehensive overview of the challenges, requirements, and best practices for safely working with highly potent compounds in drug development and manufacturing.
-
Innovating The mAb Characterization Process11/14/2024
Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights3/5/2025
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
-
Patented Process For Intermediates Useful For Etrasimod Arginine3/13/2026
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
Improved Cell Viability For Multi-Day Cell-Based Assays7/24/2025
Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
What Is DMPK, And Why Does It Matter In Drug Development?5/1/2025
By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.
DRUG DEVELOPMENT SOLUTIONS
-
The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.
-
Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.
The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.
-
Accelerate single-cell and low-volume workflows with high precision, fast setup, and surfactant-free dispensing that delivers reproducible results and flexible performance across cell types and reagents.
-
Learn more about important considerations in peptides and SEC column separation and a SEC column technology solution.
-
Optical microscope Leica DM2500 LED
Leica DM2500 LED optical microscopes are tools for demanding tasks in life science routine and research applications. With their transmitted light illumination, optical performance, and state-of-the-art accessories, they are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.